Eytan Abraham

USPTO Granted Patents = 17 (Patent Applications = 16)

CIPO Patents = 3 (Patent Applications = 10)

EPO Patents = 2 (Patent Applications = 13)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 75(Granted Patents)

Location History:

Frederick, MD (US) (2016 - 2020)
Walkersville, MD (US) (2022 - 2023)
Potomac, MD (US) (2023)

Company Filing History:

9 out of 24

Lonza Walkersville, Inc.

The Brigham and Women's Hospital, Inc.

patents

7. 1 out of 8,373

Massachusetts Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12352625 - Automated control of cell culture using Raman spectroscopy (2025-07-08),

2. 12247188 - Cell culture chamber with improved cell-contacting surfaces (2025-03-11),

3. 12163146 - Quality control methods for automated cell processing (2024-12-10),

4. 11827902 - End-to-end cell therapy automation (2023-11-28),

5. 11781113 - End-to-end cell therapy automation (2023-10-10),

6. 11773365 - Cell concentration methods and devices for use in automated bioreactors (2023-10-03),

7. 11655481 - Methods for nuclear reprogramming using synthetic transcription factors (2023-05-23),

8. 11609120 - Automated control of cell culture using Raman spectroscopy (2023-03-21),

9. 11560545 - Polymeric carriers and methods (2023-01-24),

10. 11447745 - End-to-end cell therapy automation (2022-09-20),

11. 11371018 - End-to-end cell therapy automation (2022-06-28),

12. 10851347 - Altered adherent stromal cells and methods of producing and using same (2020-12-01),

13. 10351910 - Gene and protein expression properties of adherent stromal cells cultured in 3D (2019-07-16),

14. 9950014 - Methods for prevention and treatment of preeclampsia (2018-04-24),

15. D802157 - Carrier for cell culture (2017-11-07),

Title: Eytan Abraham: Innovator in Cellular Technology

Introduction

Eytan Abraham, an accomplished inventor based in Frederick, MD, has made significant contributions to the field of cellular technology. With a total of six patents to his name, his work focuses on enhancing the capabilities and applications of adherent stromal cells.

Latest Patents

Eytan Abraham's most recent patents include innovative methods for producing and utilizing altered adherent stromal cells. His patent titled "Altered adherent stromal cells and methods of producing and using same" outlines novel approaches in cellular manipulation. Another significant patent, "Gene and protein expression properties of adherent stromal cells cultured in 3D," delves into the distinct characteristics of adherent stromal cells cultivated in three-dimensional environments versus traditional two-dimensional conditions.

Career Highlights

Eytan is currently associated with Pluristem Ltd., where his expertise in cellular technologies is utilized to drive innovation. His work not only enhances the understanding of cellular cultures but also opens avenues for breakthrough applications in regenerative medicine.

Collaborations

Throughout his career, Eytan has collaborated with notable professionals including Harel Kasuto and Zami Aberman. These partnerships have further strengthened his research and development efforts, facilitating progress in the field of cellular therapy.

Conclusion

Eytan Abraham stands out as a leading inventor in the realm of cellular innovation. His pioneering patents and collaborative work continue to contribute significantly to advancements in medical technology, exhibiting his commitment to enhancing cellular applications for future healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.